• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Duke’s Digital Innovation Team on how to Build a Collaboration Road Map

Share:

December 9, 2020

Within the last decade we’ve seen an uptick in collaboration efforts between academic medical centers (AMC) and digital health companies. However, navigating AMC’s complex ecosystems is often a challenge for potential partners.

“AMCs are different than hospitals. They have a triple mission of clinical care, medical research and health education. But they also are increasingly collaborative. They are looking to work with digital health companies,” Dinesh Divakaran, director of digital innovation at Duke Health and Duke University, said during HIMSS’ Machine Learning & AI for Healthcare conference yesterday.

“These collaborations can help both parties, that is, digital health companies and AMCs, develop, validate, translate and scale the best that digital health innovation can offer for improvement.”

Divakaran said the first step to collaboration is learning how the system works, and is more about the traditional pathways.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“It is important to understand how innovation and collaboration work at academic medical centers. There are established pathways for developing therapeutics, medical devices and diagnostics the AMCs have been doing that for decades,” he said. “But those well-traveled pathways do not translate into the digital health domain.”

Specifically, these traditional pathways aren’t designed to address questions pressing for digital collaborations, such as restrictions around accessing patient data, intellectual property considerations and speed of innovation.

Another major element of working with AMCs is knowing the stakeholders and when to work with each group.

“These stakeholders are extremely important and have different roles to play. If you do not understand how to work with different stakeholders the whole process may seem like a maze,” he said. “The stakeholders are primarily decision-makers, slash advocates. The second stakeholder is a facilitator, and the third are influencers, and the fourth are gate-keepers.”

At Duke University and Duke Health, Divakaran and his team have worked on ironing out the process for startups and digital health companies looking to collaborate. His team created a flow chart designed to help, not just external digital health companies, but also internal researchers and clinicians understand the process. He now has suggestions to other centers looking to follow suit.

“Due to the intersecting rules of different stakeholders involved, it becomes difficult for not only outside digital health companies to understand how these processes play with each other, but even the AMCs can benefit by one having a single point of contact to work with digital health companies or, in the absence of [a] point of contact, develop an internal road map or flow chart for how the stakeholders are involved in different pathways,” he said.

“These road maps can help demystify the internal process for creating digital health solutions, as well as helping not only digital health companies navigate the process, but also, internally, researchers and innovators within the system will understand how to work with companies outside.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • M&A, asset sales and spin-offs in pharmaceutical and medical device industriesM&A, asset sales and spin-offs in pharmaceutical and medical device industries
  • Sparton to Be Acquired by Cerberus for $18.50/ShareSparton to Be Acquired by Cerberus for $18.50/Share
  • Novo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore BiotechNovo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore Biotech
  • Cerner Releases Open Call for EHR-Integrated Voice Assist Testing PartnersCerner Releases Open Call for EHR-Integrated Voice Assist Testing Partners
  • Shifts in Pharma’s 2020 Digital Health LandscapeShifts in Pharma’s 2020 Digital Health Landscape
  • Vietnamese Digital Health Startup Med247 Gets $4.5M in Series A FundingVietnamese Digital Health Startup Med247 Gets $4.5M in Series A Funding
  • Pioneer in Healthcare Training Acquires Med Tech InstitutePioneer in Healthcare Training Acquires Med Tech Institute
  • ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical ResearchICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications